Covalon Technologies Ltd V.COV

Alternate Symbol(s): CVALF

Healthcare Biotechnology

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.

TSXV:COV - Post by User

Covalon Technologies Ltd

Bullboard Posts

Comment by bigreturn11on Jan 28, 2020 6:12pm

128 Views

Post# 30611153

RE:RE:RE:Covalon Announces Fiscal 2019 Year-End Results

I thnk that you mean Aquaguard did $11.1M for 2019 not 2017?

digitel wrote: AcquaGuard had revenue of $11.1 million for the year ended December 31, 2017. Subtract that acquired revenue from the annual revenue of $34 million just reported and revenue significantly declined year-over-year($23 million vs. $26.7 million).

Bullboard Posts

What will the U.S. election results mean for Canada?